WallStreetZenWallStreetZen

NASDAQ: AMRX
Amneal Pharmaceuticals Inc Stock Ownership - Who owns Amneal Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amneal Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Deborah M. AutorDirector2026-05-1134,819$12.94
$450.56kSell
Tasos KonidarisExecutive Vice President CFO2026-03-0422,035$13.30
$293.07kSell
Andrew S. BoyerExecutive Vice President2026-03-0419,136$13.30
$254.51kSell
Chintu PatelCo-CEO2026-03-0428,983$13.30
$385.47kSell
Nikita ShahExecutive Vice President2026-03-0417,976$13.30
$239.08kSell
Jason B. DalyEVP Chief Legal Officer2026-03-0415,580$13.30
$207.21kSell
Chirag K. PatelPresident Co-CEO2026-03-0437,825$13.30
$503.07kSell
Jason B. DalyEVP Chief Legal Officer2026-03-03132,783$13.31
$1.77MSell
Jason B. DalyEVP Chief Legal Officer2026-03-0310,147$13.31
$135.06kSell
Andrew S. BoyerExecutive Vice President2026-03-0319,945$13.31
$265.47kSell

1 of 5

AMRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMRX insiders and whales buy or sell their stock.

AMRX Shareholders

What type of owners hold Amneal Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tushar Bhikhubhai Patel48.82%155,734,627$1.99BInsider
Gautam Patel15.04%47,989,463$613.31MInsider
Dipan 1. Patel8.43%26,905,073$343.85MInsider
Dipan Patel8.43%26,905,073$343.85MInsider
Chintu Patel8.19%26,141,773$334.09MInsider
Chirag K. Patel7.10%22,662,890$289.63MInsider
Fosun International Ltd5.77%18,407,656$235.25MInsider
Vanguard Group Inc5.61%17,907,815$228.86MInstitution
Ambient Impact Hk Ltd5.15%16,438,356$210.08MInsider
Tpg Group Holdings Sbs Advisors Inc5.08%16,213,367$207.21MInsider

1 of 3

AMRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMRX29.19%70.81%Net SellingNet Selling
INDV99.24%0.76%Net SellingNet Selling
SUPN45.23%54.77%Net BuyingNet Selling
PBH69.08%30.92%Net SellingNet Selling
HCM0.59%0.06%
View Top Pharmaceutical Stocks

Amneal Pharmaceuticals Stock Ownership FAQ

Who owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals (NASDAQ: AMRX) is owned by 48.44% institutional shareholders, 117.49% Amneal Pharmaceuticals insiders, and 0.00% retail investors. Tushar Bhikhubhai Patel is the largest individual Amneal Pharmaceuticals shareholder, owning 155.73M shares representing 48.82% of the company. Tushar Bhikhubhai Patel's Amneal Pharmaceuticals shares are currently valued at $1.96B.

If you're new to stock investing, here's how to buy Amneal Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.